A Phase 2 Study to Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and Older
Clinical trial NCT07128121 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07128121
- Sponsor
- Shenzhen Shenxin Biotechnology Co., Ltd
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-13
- Primary completion
- 2029-10-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.